SEC Form 4 · accession 0000891293-15-000054
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP, Global Medical Affairs · Director
Period of report
Oct 23, 2015
Accepted (ET)
Oct 23, 2015 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 23, 2015 | S | 900 | $1.61 | D | 1,350,950 | D | |
| Common Stock | Oct 23, 2015 | S | 8,600 | $1.62 | D | 1,342,350 | D | |
| Common Stock | Oct 23, 2015 | S | 2,200 | $1.625 | D | 1,340,150 | D | |
| Common Stock | Oct 23, 2015 | S | 3,300 | $1.63 | D | 1,336,850 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a Rule 10b5-1 trading plan.